The webinar “Minimal Residual Disease in Multiple Myeloma: Future Directions and Controversies” is a high-level clinical session scheduled for March 9, 2026, at 18:00 CET.

Serving as the second installment of a specialized series by SPCC (Sharing Progress in Cancer Care), this activity moves beyond foundational knowledge to tackle the most debated aspects of MRD in current oncology. Led by a panel of international experts including Jesús San-Miguel, Luciano Costa, and Elena Zamagni, the discussion will focus on the feasibility of MRD-driven treatment de-escalation, the challenge of spatial heterogeneity, and the integration of imaging with molecular techniques.